Company / Shareholders' Equity
Q32 Bio Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$5.7M
FY2025
5-year range
-$182.9M / $196.0M
FY2021-FY2025
Trend
+103.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 8 years, ranging from -$183M in FY2024 to $259M in FY2020.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of -53.4%.
Declined from $178M to $6M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -67.8%
- 5-Year CAGR
- -53.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -53.4%, indicating a declining trend.
- In FY2025, shareholders' equity increased 103.1% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.7M | +103.1% |
| FY2024 | -$182.9M | -202.8% |
| FY2023 | $178.0M | +4.9% |
| FY2022 | $169.7M | -13.4% |
| FY2021 | $196.0M | -24.2% |
| FY2020 | $258.5M | +31.7% |
| FY2019 | $196.4M | +597.7% |
| FY2018 | -$39.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026